From: Predictive factors for polypharmacy among child and adolescent psychiatry inpatients
 | Mono Pharmacy (n = 49) | Poly Pharmacy (n = 54) | Unadjusted OR | df | P Value | Adjusted ORa | 95% CI for OR | P Value | |||
---|---|---|---|---|---|---|---|---|---|---|---|
 | n | % | n | % |  |  |  |  |  |  |  |
Demographic | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Gender | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Male | 25 | 24.3 | 31 | 30.1 | 1.2 | 1 | 0.5 | 1.2 | 0.5 | 2.7 | 0.6 |
   Female | 24 | 23.3 | 23 | 22.3 |  |  |  |  |  |  |  |
Illness | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Diagnosis | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Psychosis | 24 | 23.3 | 12 | 11.7 | 1.4 | 1 | 0.2 | 1.6 | 0.8 | 3.2 | 0.1 |
   Mood | 20 | 19.4 | 35 | 34 |  |  |  |  |  |  |  |
   Others | 5 | 4.9 | 7 | 6.8 |  |  |  |  |  |  |  |
Comorbidity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 29 | 28.2 | 35 | 34 | 1.2 | 1 | 0.5 | 1.3 | 0.6 | 3.0 | 0.4 |
   No | 20 | 19.4 | 19 | 18.4 |  |  |  |  |  |  |  |
Psychotic symptom | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 27 | 26.2 | 33 | 32 | 1.2 | 1 | 0.5 | 1.2 | 0.5 | 2.8 | 0.5 |
   No | 22 | 21.4 | 21 | 20.4 |  |  |  |  |  |  |  |
Treatment | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Nonpharmacological | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 33 | 32 | 17 | 16.5 | 4.5 | 1 | 0.001 | 4.7 | 2.0 | 11.1 | 0.001 |
   No | 16 | 15.5 | 37 | 35.9 |  |  |  |  |  |  |  |
PRN medication | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 19 | 18.7 | 8 | 7.8 | 3.6 | 1 | 0.007 | 3.3 | 1.2 | 8.8 | 0.01 |
   No | 30 | 29.1 | 46 | 44.7 |  |  |  |  |  |  |  |
Physical restraint | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 39 | 37.9 | 32 | 31.1 | 0.4 | 1 | 0.02 | 0.3 | 0.1 | 0.8 | 0.02 |
   No | 10 | 20.4 | 22 | 40.7 |  |  |  |  |  |  |  |
Side effect | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   Yes | 35 | 18.4 | 27 | 21.4 | 1.5 | 1 | 0.3 | 1.9 | 0.7 | 4.7 | 0.2 |
   No | 19 | 34 | 22 | 26.2 |  |  |  |  |  |  |  |